187 related articles for article (PubMed ID: 28498416)
1. Association of long-chain acyl-coenzyme A synthetase 5 expression in human breast cancer by estrogen receptor status and its clinical significance.
Yen MC; Kan JY; Hsieh CJ; Kuo PL; Hou MF; Hsu YL
Oncol Rep; 2017 Jun; 37(6):3253-3260. PubMed ID: 28498416
[TBL] [Abstract][Full Text] [Related]
2. Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.
Chen WC; Wang CY; Hung YH; Weng TY; Yen MC; Lai MD
PLoS One; 2016; 11(5):e0155660. PubMed ID: 27171439
[TBL] [Abstract][Full Text] [Related]
3. Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer.
Wu X; Li Y; Wang J; Wen X; Marcus MT; Daniels G; Zhang DY; Ye F; Wang LH; Du X; Adams S; Singh B; Zavadil J; Lee P; Monaco ME
PLoS One; 2013; 8(10):e77060. PubMed ID: 24155918
[TBL] [Abstract][Full Text] [Related]
4. Molecular Characterization, Tissue Distribution Profile, and Nutritional Regulation of
Yang Z; Zhu H; Huang X; Wang A; Xie D
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742881
[TBL] [Abstract][Full Text] [Related]
5. 17β-estradiol-induced ACSL4 protein expression promotes an invasive phenotype in estrogen receptor positive mammary carcinoma cells.
Belkaid A; Ouellette RJ; Surette ME
Carcinogenesis; 2017 Apr; 38(4):402-410. PubMed ID: 28334272
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Acyl-CoA synthetase isoforms in pancreatic beta cells: Gene silencing shows participation of ACSL3 and ACSL4 in insulin secretion.
Ansari IH; Longacre MJ; Stoker SW; Kendrick MA; O'Neill LM; Zitur LJ; Fernandez LA; Ntambi JM; MacDonald MJ
Arch Biochem Biophys; 2017 Mar; 618():32-43. PubMed ID: 28193492
[TBL] [Abstract][Full Text] [Related]
7. Characterization of recombinant long-chain rat acyl-CoA synthetase isoforms 3 and 6: identification of a novel variant of isoform 6.
Van Horn CG; Caviglia JM; Li LO; Wang S; Granger DA; Coleman RA
Biochemistry; 2005 Feb; 44(5):1635-42. PubMed ID: 15683247
[TBL] [Abstract][Full Text] [Related]
8. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.
Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ
Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939
[TBL] [Abstract][Full Text] [Related]
9. The endogenous subcellular localisations of the long chain fatty acid-activating enzymes ACSL3 and ACSL4 in sarcoma and breast cancer cells.
Radif Y; Ndiaye H; Kalantzi V; Jacobs R; Hall A; Minogue S; Waugh MG
Mol Cell Biochem; 2018 Nov; 448(1-2):275-286. PubMed ID: 29450800
[TBL] [Abstract][Full Text] [Related]
10. Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin.
Durgan DJ; Smith JK; Hotze MA; Egbejimi O; Cuthbert KD; Zaha VG; Dyck JR; Abel ED; Young ME
Am J Physiol Heart Circ Physiol; 2006 Jun; 290(6):H2480-97. PubMed ID: 16428347
[TBL] [Abstract][Full Text] [Related]
11. Evolution, expression profile, and regulatory characteristics of ACSL gene family in chicken (Gallus gallus).
Tian W; Wang D; Wang Z; Jiang K; Li Z; Tian Y; Kang X; Liu X; Li H
Gene; 2021 Jan; 764():145094. PubMed ID: 32860898
[TBL] [Abstract][Full Text] [Related]
12. Human intestinal acyl-CoA synthetase 5 is sensitive to the inhibitor triacsin C.
Kaemmerer E; Peuscher A; Reinartz A; Liedtke C; Weiskirchen R; Kopitz J; Gassler N
World J Gastroenterol; 2011 Nov; 17(44):4883-9. PubMed ID: 22171129
[TBL] [Abstract][Full Text] [Related]
13. Acyl-CoA synthetase-4, a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptor-positive and -negative breast cancer.
Orlando UD; Castillo AF; Dattilo MA; Solano AR; Maloberti PM; Podesta EJ
Oncotarget; 2015 Dec; 6(40):42632-50. PubMed ID: 26536660
[TBL] [Abstract][Full Text] [Related]
14. Rat long-chain acyl-CoA synthetase mRNA, protein, and activity vary in tissue distribution and in response to diet.
Mashek DG; Li LO; Coleman RA
J Lipid Res; 2006 Sep; 47(9):2004-10. PubMed ID: 16772660
[TBL] [Abstract][Full Text] [Related]
15. Levels of acyl-coenzyme A synthetase 5 in urothelial cells and corresponding neoplasias reflect cellular differentiation.
Gaisa NT; Reinartz A; Schneider U; Klaus C; Heidenreich A; Jakse G; Kaemmerer E; Klinkhammer BM; Knuechel R; Gassler N
Histol Histopathol; 2013 Mar; 28(3):353-64. PubMed ID: 23348389
[TBL] [Abstract][Full Text] [Related]
16. Identification of ACSL4 as a biomarker and contributor of ferroptosis.
Yuan H; Li X; Zhang X; Kang R; Tang D
Biochem Biophys Res Commun; 2016 Sep; 478(3):1338-43. PubMed ID: 27565726
[TBL] [Abstract][Full Text] [Related]
17. The Diagnostic Value of ACSL1, ACSL4, and ACSL5 and the Clinical Potential of an ACSL Inhibitor in Non-Small-Cell Lung Cancer.
Ma Y; Nenkov M; Berndt A; Abubrig M; Schmidt M; Sandhaus T; Huber O; Clement JH; Lang SM; Chen Y; Gaßler N
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539505
[TBL] [Abstract][Full Text] [Related]
18. ACSL family: The regulatory mechanisms and therapeutic implications in cancer.
Quan J; Bode AM; Luo X
Eur J Pharmacol; 2021 Oct; 909():174397. PubMed ID: 34332918
[TBL] [Abstract][Full Text] [Related]
19. Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells.
Maloberti PM; Duarte AB; Orlando UD; Pasqualini ME; Solano AR; López-Otín C; Podestá EJ
PLoS One; 2010 Nov; 5(11):e15540. PubMed ID: 21085606
[TBL] [Abstract][Full Text] [Related]
20. Role of long-chain acyl-coenzyme A synthetases in the regulation of arachidonic acid metabolism in interleukin 1β-stimulated rat fibroblasts.
Kuwata H; Yoshimura M; Sasaki Y; Yoda E; Nakatani Y; Kudo I; Hara S
Biochim Biophys Acta; 2014 Jan; 1841(1):44-53. PubMed ID: 24095834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
